RPS-BLAST 2.2.22 [Sep-27-2009]

Database: CddA 
           21,609 sequences; 6,263,737 total letters

Searching..................................................done

Query= 537021.9.peg.33_1
         (100 letters)



>gnl|CDD|153174 cd04902, ACT_3PGDH-xct, C-terminal ACT (regulatory) domain of
          D-3-phosphoglycerate dehydrogenase (3PGDH).  The
          C-terminal ACT (regulatory) domain of
          D-3-phosphoglycerate dehydrogenase (3PGDH), with an
          extended C-terminal (xct) region from bacteria,
          archaea, fungi, and plants. 3PGDH is an enzyme that
          belongs to the D-isomer specific, 2-hydroxyacid
          dehydrogenase family and catalyzes the oxidation of
          D-3-phosphoglycerate to 3- phosphohydroxypyruvate,
          which is the first step in the biosynthesis of
          L-serine, using NAD+ as the oxidizing agent. In
          bacteria, 3PGDH is feedback-controlled by the end
          product L-serine in an allosteric manner. Some 3PGDH
          enzymes have an additional domain formed by an extended
          C-terminal region. This additional domain introduces
          significant asymmetry to the homotetramer. Adjacent ACT
          (regulatory) domains interact, creating two
          serine-binding sites, however, this asymmetric
          arrangement results in the formation of two different
          and distinct domain interfaces between identical
          domains in the asymmetric unit. How this asymmetry
          influences the mechanism of effector inhibition is
          still unknown. Members of this CD belong to the
          superfamily of ACT regulatory domains.
          Length = 73

 Score = 62.5 bits (153), Expect = 2e-11
 Identities = 27/73 (36%), Positives = 38/73 (52%)

Query: 25 MICIVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEHAISFLCIDGSILNSVLEKLS 84
          M+ + N D  G++  VG ILGE GINIA   +GR +    A+  L +D  + + VLE+L 
Sbjct: 1  MLVVRNTDRPGVIGKVGTILGEAGINIAGMQVGRDEPGGEALMVLSVDEPVPDEVLEELR 60

Query: 85 VNVTIRFVKQFEF 97
              I   K  E 
Sbjct: 61 ALPGILSAKVVEL 73


>gnl|CDD|153151 cd04879, ACT_3PGDH-like, ACT_3PGDH-like CD includes the
          C-terminal ACT (regulatory) domain of
          D-3-phosphoglycerate dehydrogenase (3PGDH).
          ACT_3PGDH-like: The ACT_3PGDH-like CD includes the
          C-terminal ACT (regulatory) domain of
          D-3-phosphoglycerate dehydrogenase (3PGDH), with or
          without an extended C-terminal (xct) region found in
          various bacteria, archaea, fungi, and plants. 3PGDH is
          an enzyme that belongs to the D-isomer specific,
          2-hydroxyacid dehydrogenase family and catalyzes the
          oxidation of D-3-phosphoglycerate to 3-
          phosphohydroxypyruvate, which is the first step in the
          biosynthesis of L-serine, using NAD+ as the oxidizing
          agent. In bacteria, 3PGDH is feedback controlled by the
          end product L-serine in an allosteric manner. In the
          Escherichia coli homotetrameric enzyme, the interface
          at adjacent ACT (regulatory) domains couples to create
          an extended beta-sheet. Each regulatory interface forms
          two serine-binding sites. The mechanism by which serine
          transmits inhibition to the active site is postulated
          to involve the tethering of the regulatory domains
          together to create a rigid quaternary structure with a
          solvent-exposed active site cleft. This CD also
          includes the C-terminal ACT domain of the L-serine
          dehydratase (LSD), iron-sulfur-dependent, beta subunit,
          found in various bacterial anaerobes such as
          Clostridium, Bacillus, and Treponema species. LSD
          enzymes catalyze the deamination of L-serine, producing
          pyruvate and ammonia. Unlike the eukaryotic L-serine
          dehydratase, which requires the pyridoxal-5'-phosphate
          (PLP) cofactor, the prokaryotic L-serine dehydratase
          contains an [4Fe-4S] cluster instead of a PLP active
          site. The LSD alpha and beta subunits of the
          'clostridial' enzyme are encoded by the sdhA and sdhB
          genes. The single subunit bacterial homologs of
          L-serine dehydratase (LSD1, LSD2, TdcG) present in E.
          coli, and other Enterobacteriales, lack the ACT domain
          described here. Members of this CD belong to the
          superfamily of ACT regulatory domains.
          Length = 71

 Score = 56.3 bits (137), Expect = 2e-09
 Identities = 24/59 (40%), Positives = 35/59 (59%)

Query: 25 MICIVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEHAISFLCIDGSILNSVLEKL 83
           + IV+ D+ G++  VG ILGE+GINIA   +GR +    A   L +D  +   VLE+L
Sbjct: 1  RLLIVHKDVPGVIGKVGTILGEHGINIAAMQVGRKEKGGIAYMVLDVDSPVPEEVLEEL 59


>gnl|CDD|153175 cd04903, ACT_LSD, C-terminal ACT domain of the L-serine
          dehydratase (LSD), iron-sulfur-dependent, beta subunit.
           The C-terminal ACT domain of the L-serine dehydratase
          (LSD), iron-sulfur-dependent, beta subunit, found in
          various bacterial anaerobes such as Clostridium,
          Bacillis, and Treponema species. These enzymes catalyze
          the deamination of L-serine, producing pyruvate and
          ammonia. Unlike the eukaryotic L-serine dehydratase,
          which requires the pyridoxal-5'-phosphate (PLP)
          cofactor, the prokaryotic L-serine dehydratase contains
          an [4Fe-4S] cluster instead of a PLP active site. The
          LSD alpha and beta subunits of the 'clostridial' enzyme
          are encoded by the sdhA and sdhB genes. The single
          subunit bacterial homologs of L-serine dehydratase
          (LSD1, LSD2, TdcG) present in Escherichia coli, and
          other enterobacterials, lack the ACT domain described
          here. Members of this CD belong to the superfamily of
          ACT regulatory domains.
          Length = 71

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 15/56 (26%), Positives = 31/56 (55%)

Query: 28 IVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEHAISFLCIDGSILNSVLEKL 83
          +V+ D  G +  V ++L ++ INIA   + R +  + A+  + +D  I   V+E++
Sbjct: 4  VVHKDKPGAIAKVTSVLADHEINIAFMRVSRKEKGDQALMVIEVDQPIDEEVIEEI 59


>gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically
          binding an amino acid or other small ligand leading to
          regulation of the enzyme.  Members of this CD belong to
          the superfamily of ACT regulatory domains. Pairs of ACT
          domains are commonly involved in specifically binding
          an amino acid or other small ligand leading to
          regulation of the enzyme. The ACT domain has been
          detected in a number of diverse proteins; some of these
          proteins are involved in amino acid and purine
          biosynthesis, phenylalanine hydroxylation, regulation
          of bacterial metabolism and transcription, and many
          remain to be characterized. ACT domain-containing
          enzymes involved in amino acid and purine synthesis are
          in many cases allosteric enzymes with complex
          regulation enforced by the binding of ligands. The ACT
          domain is commonly involved in the binding of a small
          regulatory molecule, such as the amino acids L-Ser and
          L-Phe in the case of D-3-phosphoglycerate dehydrogenase
          and the bifunctional chorismate mutase-prephenate
          dehydratase enzyme (P-protein), respectively.
          Aspartokinases typically consist of two C-terminal ACT
          domains in a tandem repeat, but  the second ACT domain
          is inserted within the first, resulting in, what is
          normally the terminal beta strand of ACT2, formed from
          a region N-terminal of ACT1. ACT domain repeats have
          been shown to have nonequivalent ligand-binding sites
          with complex regulatory patterns such as those seen in
          the bifunctional enzyme, aspartokinase-homoserine
          dehydrogenase (ThrA). In other enzymes, such as
          phenylalanine hydroxylases, the ACT domain appears to
          function as a flexible small module providing
          allosteric regulation via transmission of
          conformational changes, these conformational changes
          are not necessarily initiated by regulatory ligand
          binding at the ACT domain itself. ACT domains are
          present either singularly, N- or C-terminal, or in
          pairs present C-terminal or between two catalytic
          domains. Unique to cyanobacteria are four ACT domains
          C-terminal to an aspartokinase domain. A few proteins
          are composed almost entirely of ACT domain repeats as
          seen in the four ACT domain protein, the ACR protein,
          found in higher plants; and the two ACT domain protein,
          the glycine cleavage system transcriptional repressor
          (GcvR) protein, found in some bacteria. Also seen are
          single ACT domain proteins similar to the Streptococcus
          pneumoniae ACT domain protein (uncharacterized pdb
          structure 1ZPV) found in both bacteria and archaea.
          Purportedly, the ACT domain is an evolutionarily mobile
          ligand binding regulatory module that has been fused to
          different enzymes at various times.
          Length = 60

 Score = 31.5 bits (72), Expect = 0.046
 Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 1/59 (1%)

Query: 26 ICIVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEHAISFLCIDGS-ILNSVLEKL 83
          + +   D  G++  V ++L E GINI       S     A  F+ +DG   L  +LE L
Sbjct: 1  LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGDGDLEKLLEAL 59


>gnl|CDD|153173 cd04901, ACT_3PGDH, C-terminal ACT (regulatory) domain of
          D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in
          fungi and bacteria.  The C-terminal ACT (regulatory)
          domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH)
          found in fungi and bacteria. 3PGDH is an enzyme that
          belongs to the D-isomer specific, 2-hydroxyacid
          dehydrogenase family and catalyzes the oxidation of
          D-3-phosphoglycerate to 3- phosphohydroxypyruvate,
          which is the first step in the biosynthesis of
          L-serine, using NAD+ as the oxidizing agent. In
          Escherichia coli, the SerA 3PGDH is feedback-controlled
          by the end product L-serine in an allosteric manner. In
          the homotetrameric enzyme, the interface at adjacent
          ACT (regulatory) domains couples to create an extended
          beta-sheet. Each regulatory interface forms two
          serine-binding sites. The mechanism by which serine
          transmits inhibition to the active site is postulated
          to involve the tethering of the regulatory domains
          together to create a rigid quaternary structure with a
          solvent-exposed active site cleft. Members of this CD
          belong to the superfamily of ACT regulatory domains.
          Length = 69

 Score = 27.1 bits (61), Expect = 1.2
 Identities = 20/68 (29%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 26 ICIVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEHAISFLCID--GSILNSVLEKL 83
          I  ++ ++ G++  +  IL E+ INIA  +L     T   I ++ ID    +   +LE L
Sbjct: 2  ILHIHKNVPGVLGQINTILAEHNINIAAQYL----QTRGEIGYVVIDIDSEVSEELLEAL 57

Query: 84 -SVNVTIR 90
           ++  TIR
Sbjct: 58 RAIPGTIR 65


>gnl|CDD|177049 CHL00127, rpl11, ribosomal protein L11; Validated.
          Length = 140

 Score = 27.0 bits (60), Expect = 1.3
 Identities = 8/15 (53%), Positives = 11/15 (73%)

Query: 40 VGNILGEYGINIAHF 54
          VG  LG++G+NI  F
Sbjct: 24 VGPALGQHGVNINLF 38


>gnl|CDD|145157 pfam01842, ACT, ACT domain.  This family of domains generally
          have a regulatory role. ACT domains are linked to a
          wide range of metabolic enzymes that are regulated by
          amino acid concentration. Pairs of ACT domains bind
          specifically to a particular amino acid leading to
          regulation of the linked enzyme. The ACT domain is
          found in: D-3-phosphoglycerate dehydrogenase
          EC:1.1.1.95, which is inhibited by serine.
          Aspartokinase EC:2.7.2.4, which is regulated by lysine.
          Acetolactate synthase small regulatory subunit, which
          is inhibited by valine. Phenylalanine-4-hydroxylase
          EC:1.14.16.1, which is regulated by phenylalanine.
          Prephenate dehydrogenase EC:4.2.1.51.
          formyltetrahydrofolate deformylase EC:3.5.1.10, which
          is activated by methionine and inhibited by glycine.
          GTP pyrophosphokinase EC:2.7.6.5.
          Length = 66

 Score = 26.5 bits (59), Expect = 1.6
 Identities = 14/57 (24%), Positives = 22/57 (38%), Gaps = 1/57 (1%)

Query: 28 IVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEHAISFLCI-DGSILNSVLEKL 83
          +   D  G++  V   L + GINI       S      +  + + D   L + LE L
Sbjct: 5  VGVPDRPGLLARVFGALADRGINIESISQSTSGDKAGIVFIVVVVDEEDLEAALEAL 61


>gnl|CDD|153144 cd04872, ACT_1ZPV, ACT domain proteins similar to the yet
          uncharacterized Streptococcus pneumoniae ACT domain
          protein.  This CD, ACT_1ZPV, includes those single ACT
          domain proteins similar to the yet uncharacterized
          Streptococcus pneumoniae ACT domain protein (pdb
          structure 1ZPV). Members of this CD belong to the
          superfamily of ACT regulatory domains.
          Length = 88

 Score = 26.0 bits (58), Expect = 2.1
 Identities = 11/29 (37%), Positives = 16/29 (55%)

Query: 23 RLMICIVNADILGIVVFVGNILGEYGINI 51
          + +I +V  D +GIV  V   L E  +NI
Sbjct: 1  KAVITVVGKDRVGIVAGVSTKLAELNVNI 29


>gnl|CDD|37481 KOG2270, KOG2270, KOG2270, Serine/threonine protein kinase involved
           in cell cycle control [Signal transduction mechanisms,
           Cell cycle control, cell division, chromosome
           partitioning].
          Length = 520

 Score = 25.7 bits (56), Expect = 2.6
 Identities = 19/47 (40%), Positives = 26/47 (55%), Gaps = 7/47 (14%)

Query: 59  SQSTE----HAISFLCIDGSILNSVLEKLSVNV-TIRFVKQFEFNVD 100
           SQS E    HA+ FL +D + +N    +L V V T+R +  FEF  D
Sbjct: 309 SQSVEHDHPHALDFLRMDCNNVNDFFRRLGVAVMTVREL--FEFITD 353


>gnl|CDD|31346 COG1152, CdhA, CO dehydrogenase/acetyl-CoA synthase alpha subunit
           [Energy production and conversion].
          Length = 772

 Score = 24.9 bits (54), Expect = 4.6
 Identities = 9/24 (37%), Positives = 14/24 (58%)

Query: 18  DVDIGRLMICIVNADILGIVVFVG 41
           DV+I  + + IV   I GI+  +G
Sbjct: 484 DVEIRNVGVPIVMGTIPGIIAVIG 507


>gnl|CDD|32333 COG2150, COG2150, Predicted regulator of amino acid metabolism,
           contains ACT domain [General function prediction only].
          Length = 167

 Score = 24.8 bits (54), Expect = 5.3
 Identities = 14/84 (16%), Positives = 37/84 (44%), Gaps = 1/84 (1%)

Query: 1   VFSDGKPRFIKIQEINFDVDIGRLMICIVNADILGIVVFVGNILGEYGINIAHFHLGRSQ 60
           +F + +P    + ++   + +G + I   +A   GI+  V +++ + GI+I        +
Sbjct: 74  IFENLEPV-ASLADVAPLLGLGVIEIYPEDARYPGILAGVASLIAKRGISIRQIISEDPE 132

Query: 61  STEHAISFLCIDGSILNSVLEKLS 84
             E     +  +  I   ++++L 
Sbjct: 133 LQEEPKLTIVTERPIPGDLIDELK 156


>gnl|CDD|31131 COG0788, PurU, Formyltetrahydrofolate hydrolase [Nucleotide
          transport and metabolism].
          Length = 287

 Score = 24.8 bits (54), Expect = 5.5
 Identities = 14/78 (17%), Positives = 24/78 (30%), Gaps = 11/78 (14%)

Query: 28 IVNADILGIVVFVGNILGEYGINIAHFHLGRSQSTEH---AISFLCIDGSI--------L 76
          +   D  GIV  +   L E+G NI          T      + F    G +         
Sbjct: 12 VSCPDQPGIVAAISGFLAEHGCNIVDSDQFDDPETGRFFMRVEFEGEGGPLDREALRAAF 71

Query: 77 NSVLEKLSVNVTIRFVKQ 94
            + E+  ++  +    Q
Sbjct: 72 APLAEEFGMDWRLHDAAQ 89


>gnl|CDD|32505 COG2358, Imp, TRAP-type uncharacterized transport system,
           periplasmic component [General function prediction
           only].
          Length = 321

 Score = 24.5 bits (53), Expect = 5.8
 Identities = 17/82 (20%), Positives = 25/82 (30%), Gaps = 19/82 (23%)

Query: 31  ADILGIVVFVGN-----------ILGEYGINIAHFHLGRSQSTEHAISFLC---IDGSIL 76
           AD+ G  V +G            IL   GI    + L        +   L    ID +  
Sbjct: 133 ADLKGKRVAIGPPGSGTEATARQILEALGITYDDYELDLGLGDAESADALKNGTIDAAFY 192

Query: 77  -----NSVLEKLSVNVTIRFVK 93
                N  + +L+    I  V 
Sbjct: 193 VAGVPNPAISELATTCDIVLVP 214


  Database: CddA
    Posted date:  Feb 4, 2011  9:38 PM
  Number of letters in database: 6,263,737
  Number of sequences in database:  21,609
  
Lambda     K      H
   0.329    0.147    0.428 

Gapped
Lambda     K      H
   0.267   0.0739    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 21609
Number of Hits to DB: 1,198,447
Number of extensions: 57594
Number of successful extensions: 198
Number of sequences better than 10.0: 1
Number of HSP's gapped: 198
Number of HSP's successfully gapped: 19
Length of query: 100
Length of database: 6,263,737
Length adjustment: 68
Effective length of query: 32
Effective length of database: 4,794,325
Effective search space: 153418400
Effective search space used: 153418400
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.7 bits)
S2: 51 (23.4 bits)